C4 Therapeutics Inc. (NASDAQ: CCCC) Stock Information | RedChip

C4 Therapeutics Inc. (NASDAQ: CCCC)


$3.9500
+0.2100 ( +2.87% ) 700.7K

C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.

Market Data


Open


$3.9500

Previous close


$3.7400

Volume


700.7K

Market cap


$278.12M

Day range


$3.6960 - $4.0700

52 week range


$3.3800 - $11.8800

SEC Filings


Form Type Description Pages Date
sc Insider transactions 1 Nov 14, 2024
sc Insider transactions 1 Nov 14, 2024
sc Insider transactions 1 Nov 14, 2024
sc Insider transactions 1 Nov 14, 2024
sc Insider transactions 1 Nov 14, 2024
sc Insider transactions 1 Nov 14, 2024
effect Other 1 Nov 13, 2024
effect Other 1 Nov 13, 2024
suppl Other 4 Nov 13, 2024
suppl Other 2 Nov 13, 2024

Latest News


× Before browsing our site, please accept our cookies policy